期刊文献+

普罗布考通过调节肝癌细胞HepG2代谢重编程逆转Warburg效应抑制其转移和侵袭的机制研究 被引量:3

Probucol inhibited metastasis and invasion by reversing Warburg effect and regulated reprogramming of hepatoma cell HepG2
下载PDF
导出
摘要 目的:研究普罗布考调节HepG2的代谢重编程逆转Warburg效应抑制其转移和侵袭的机制,为脂代谢调节药物的研究提供支持。方法:HepG2细胞体外培养后分为对照组(NC)、高剂量组(High)、中剂量组(Middle)和低剂量组(Low),其中高、中、低剂量组的细胞分别使用100、50、10μmol/L的普罗布考干预。CCK-8检测细胞活力,流式细胞术检测细胞周期的变化,细胞划痕实验检测细胞转移能力,Transwell小室实验检测细胞侵袭能力,Western blot法检测细胞中己糖激酶(HK)、丙酮酸激酶(PK)、乳酸脱氢酶(LDH)、磷酸果糖激酶(PFKP)、丙酮酸脱氢酶(PDH)以及柠檬酸合酶(CS)的表达变化,试剂盒检测培养基中乳酸的含量,ECAR检测细胞糖酵解的压力,929 oxygen system检测细胞对于氧气的吸收水平检测。结果:普罗布考可以抑制HepG2的增殖,且有剂量依赖,还可以阻滞细胞周期。普罗布考可以提高HK、PK、LDH、PFKP以及PDH和CS的表达,增加耗氧量减少乳酸的产生,促进细胞的三羧酸循环。普罗布考还可以抑制HepG2的侵袭和迁移能力。结论:普罗布考可以调节肝癌细胞HepG2的代谢重编程、逆转Warburg效应从而抑制肿瘤细胞的增殖、迁移和侵袭。 AIM: To study the mechanism of probucol-modulated the metabolic reprogramming of HepG2,reversed the Warburg effect and inhibited its metastasis and invasion,so as to provide support for the research of lipid metabolism regulating drugs.METHODS: HepG2 cells were divided into control group( NC),high dose group( High),middle dose group( Middle) and low dose group( Low) after cultured in vitro. The cells in the high dose,middle dose and low dose group were treated with probucol of 100,50,10 μmol/L,respectively. CCK-8 was used to detect cell viability; the cell cycle changes were detected by flow cytometry; the cell migration assay was performed by cell scratch test; the cell invasion ability was detected by Transwell experiment;the expression of hexokinase( HK),pyruvate kinase( PK),lactate dehydrogenase( LDH),phospho fructose kinase( PFKP),pyruvate dehydrogenase( PDH) and citric acid synthase( CS) in cells were detected by Western blot; the level of lactic acid in the medium was detected by the kit; the pressure of glycolysis was detected by ECAR; and the oxygen absorption was detected by the 929 oxygen system.RESULTS: Probucol dose-dependently inhibited the proliferation of HepG2,and blocked cell cycle. Probucol increased the expression of HK,PK,LDH,PFKP,PDH and CS,increased oxygen consumption and reduced the production of lactic acid,and promoted the cycle of three carboxylic acids. Probucol also inhibited the invasion and migration of HepG2.CONCLUSION: Probucol can regulate the metabolic reprogramming,reverse the Warburg effect of hepatoma cell HepG2,which can inhibit the proliferation,migration and invasion of tumor cells.
作者 王瑾 杨毅 郭丽 李文燕 阮水良 WANG Jin;YANG Yi;GUO Li;LI Wenyan;RUAN Shuiliang(The Second Hospital of Jiaxing,Jiaxing 314001,Zhejiang,China)
机构地区 嘉兴市第二医院
出处 《中国临床药理学与治疗学》 CAS CSCD 2018年第6期601-607,共7页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 浙江省科技厅项目(2017C37174)
关键词 普罗布考 代谢重编程 Warburg效应 侵袭 probucol metabolic reprogram-ruing Warburg effect invasion
  • 相关文献

参考文献5

二级参考文献92

  • 1段俊国,廖品正,吴烈,李毓敏,余杨桂,邱波,李传课.中药复方芪明颗粒治疗糖尿病视网膜病变双盲双模拟随机对照多中心临床研究[J].成都中医药大学学报,2006,29(2):1-5. 被引量:74
  • 2赵水平,洪绍彩,邓平,吴智鸿.普罗布考对主动脉粥样斑块形成及血栓调节蛋白的影响[J].中国动脉硬化杂志,2006,14(6):503-507. 被引量:12
  • 3Nathan DM, Cleary PA, Backlund JY,et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group-Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes[J]. N Engl J Med,2005,353(25) :2 643-653.
  • 4Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes[ J]. N Engl J Med, 2008, 359(15) : 1 565-576.
  • 5Giacco F, Brownlee M. Oxidative stress and diabetic complications [J]. Circ Res, 2010, 107(9) :1 058-070.
  • 6Agardh E, Hultberg B, Agardh C. Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities irt diabetic rats[J]. Curt Eye Res ,2000,21 ( 1 ) :543- 549.
  • 7U.K. Prospective Diabetes Study. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk for complications in patients with type 2 diabetes ( UKPDS 33) [J]. Lancet,1998,352(9131 ) :837-853.
  • 8Yamagishi S, Ueda S, Matsui T, et al. Role of advanced glycation end products ( AGEs ) and oxidative stress in diabetic retinopathy [J]. Curt Pharm Des,2008,14(10) : 962-968.
  • 9Doggrell SA. Immunomodulation with DiNAC-a new approach to the treatment of atherosclerosis [ J ]. Expert Opin Investig Drugs, 2002,11 (5) : 717-720.
  • 10Rema M, Srivastava BK, Anitha B, et al. Association of serum lipids with diabetic retinopathy in urban South Indians-the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-2 [ J ]. Diabet Med ,2006,23 (9) : 1 029-036.

共引文献33

同被引文献15

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部